# Prevalence Survey of Antimalarial Drug Resistance Markers

> **NCT03217851** · — · COMPLETED · sponsor: **University of Oxford** · enrollment: 4000 (actual)

## Conditions studied

- Malaria

## Interventions

- **DIAGNOSTIC_TEST:** Blood Collection
- **DIAGNOSTIC_TEST:** Dried Blood Spot

## Key facts

- **NCT ID:** NCT03217851
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-18
- **Primary completion:** 2021-12-24
- **Final completion:** 2021-12-24
- **Target enrollment:** 4000 (ACTUAL)
- **Last updated:** 2022-06-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03217851

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03217851, "Prevalence Survey of Antimalarial Drug Resistance Markers". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03217851. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*